Patent details
LUC00057 Product Name: Antibody molecule having specificity for human CD22 comprising light and heavy chain variable domain complementarity determining region (CDR) sequences according to claim 1 of the basic patent, such as an antibody molecule comprising the light and heavy chain variable region sequences according to claim 10 of the basic patent, in particular an antibody molecule comprising inotuzumab; wherein the antibody molecule is covalently linked to a toxin, in particular ozogamicin; such as inotuzumab ozogamicin, or a derivative or variant thereof protected by the basic patent
Basic Information
- Publication number:
- LUC00057
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP037189743
- Legal Status:
- Active
- Application number:
- LUC00057
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/17/1200/001
- Marketing Authorization Type:
- Marketing Authorization Date:
- 03/07/2017
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 21/12/2017
- First Marketing Authorization date:
- 03/07/2017
- Grant date:
- 26/02/2018
- Activation date:
- 02/05/2023
- Publication date:
- 27/12/2017
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 02/05/2028
- SPC Extension Expiration:
- 02/05/2028
- Rejection date:
- Withdrawal date:
Owner
- From:
- 21/12/2017
- Name:
- UCB Pharma, S.A.
- Address:
- Allée de la Recherche 60, 1070 Bruxelles, Belgium (BE)
Agent
- Name:
- DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT
- From:
- 21/12/2017
- Address:
- PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2018/02
- Publication date:
- 15/01/2018
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2018/04
- Publication date:
- 23/03/2018
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2023/07
- Publication date:
- 06/06/2023
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- 01/06/2026
- Annual Fee Number:
- 24
- Annual Fee Amount:
- 440 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 29/04/2025
- Last Annual Fee Paid Number:
- 23
- Last Annual Fee Paid Amount:
- 430 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 26/02/2018 | Publication | 1 |
| 21/12/2017 | General Document | 41 |
| 21/12/2017 | Application Form | 5 |
| 27/12/2017 | Publication | 1 |
| 26/02/2018 | Certificate | 2 |
| 27/12/2017 | Outgoing Correspondence | 1 |